Sugi Predict
/ Targets
/ TMED2
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to TMED2 by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101) |
PHASE1/PHASE2 | COMPLETED |
| Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma |
PHASE2 | RECRUITING |
| Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients |
PHASE1 | UNKNOWN |
| Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression |
nan | NOT_YET_RECRUITING |
| Immunophenotypic Evaluation of CD305 and CD85d in B-Cell Lymphoid Neoplasms |
nan | NOT_YET_RECRUITING |
| Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors |
nan | NOT_YET_RECRUITING |
| Evaluation of CEMIP in Pancreatic Cancer |
nan | UNKNOWN |
| Genome Environment Microbiome and Metabolome in Autism Study |
nan | COMPLETED |
| Role of Sorcin and Annexin A3 in Breast Cancer Patients |
nan | UNKNOWN |
| FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application |
nan | COMPLETED |
| Exome Analysis in Hearing Impaired Patients |
nan | UNKNOWN |
| Transcriptomic Profile of Patients Treated With Different Modalities of Spinal Cord Stimulation |
nan | UNKNOWN |
| Study of the Genetic Factors Involved in Autism and Related Disorders |
nan | RECRUITING |
| Genetic Analysis of Hereditary Disorders of Hearing and Balance |
nan | COMPLETED |
| Cell Free Circulating Nucleic Acids as New Tumor Diagnostics From Human Plasma Samples. |
nan | UNKNOWN |
| Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA |
nan | RECRUITING |
| Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others |
nan | RECRUITING |
| Pathophysiology of Paget's Disease of Bone |
nan | COMPLETED |
| The Role of Programmed Death Ligand -1 (Pdl-1) in Lung Cancer |
nan | COMPLETED |
| Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients |
nan | UNKNOWN |
| Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages |
nan | COMPLETED |
| Immune Cell Response to Stimuli |
nan | RECRUITING |
| Genetic Characterization of Parkinson's Disease |
nan | COMPLETED |
| Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia |
nan | RECRUITING |
| The Etiology and Progression of Brain Tumors |
nan | COMPLETED |
| Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. |
nan | UNKNOWN |
| Genetic Analyses of Nonsyndromic and Syndromic Deafness in Pakistan |
nan | ENROLLING_BY_INVITATION |
| Detection of Circulating Biomarkers of Immunogenic Cell Death |
nan | COMPLETED |
| Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids |
nan | RECRUITING |
| Genes, Proteins, and Metabolites in Drug-resistant Epilepsy (DRE) Patients |
nan | NOT_YET_RECRUITING |
Related proteins — ESM-2 sequence neighbours (a TMED2 binder may also engage these)